Long Noncoding RNA MIR100HG Knockdown Attenuates Hepatocellular Carcinoma Progression by Regulating MicroRNA-146b-5p/Chromobox 6

Overview

Journal Gastroenterol Res Pract

Publisher Wiley

Specialty Gastroenterology

Date 2021 Aug 12

PMID 34381502

Citations 8

Authors

Fushun Li

Xianghua Sun

Qing Liu

Xilu Liu

Jia Zhang

Affiliations

Soon will be listed here.

Abstract

Purpose: Hepatocellular carcinoma (HCC) accounts for approximately ninety percent of primary liver cancer. This study attempted to investigate the effects of the long noncoding RNA MIR100HG (MIR100HG) in HCC and the underlying molecular mechanism.

Materials And Methods: qRT-PCR was implemented to analyze the expression of MIR100HG, microRNA-146b-5p (miR-146b-5p), and Chromobox 6 (CBX6). The correlation between MIR100HG and clinicopathological features of HCC patients was assessed. Additionally, the effects of MIR100HG knockdown on HCC cell viability, migration, and invasion were explored. The interactions among MIR100HG, miR-146b-5p, and CBX6 were confirmed. Furthermore, rescue experiments were conducted to investigate whether MIR100HG knockdown modulates HCC cell behaviors through modulating the miR-146b-5p/CBX6 axis.

Results: The expression of MIR100HG and CBX6 was enhanced, while miR-146b-5p was inhibited in HCC cells. High MIR100HG expression was positively associated with the TNM tumor stage and Edmondson-Steiner grading in HCC patients. MIR100HG knockdown considerably reduced the HCC cell viability, migration, and invasion. In addition, MIR100HG directly targeted miR-146b-5p, and miR-146b-5p directly targeted CBX6 in HCC cells. Moreover, miR-146b-5p suppression or CBX6 elevation evidently rescued the suppressed viability, migration, and invasion of HCC cells caused by MIR100HG knockdown.

Conclusions: Knockdown of MIR100HG inhibited the viability, migration, and invasion of HCC cells by targeting the miR-146b-5p/CBX6 axis, offering a potential therapeutic target for HCC therapy.

Citing Articles

LncRNA MIR100HG affects the proliferation and metastasis of lung cancer cells through mediating the microRNA-5590-3p/DCBLD2 axis.

Min S, Zhang L, Zhang L, Liu F, Liu M Immun Inflamm Dis. 2024; 12(4):e1223.

PMID: 38602284 PMC: 11007817. DOI: 10.1002/iid3.1223.

A concise review on the role of MIR100HG in human disorders.

Ghafouri-Fard S, Harsij A, Farahzadi H, Hussen B, Taheri M, Mokhtari M J Cell Mol Med. 2023; 27(16):2278-2289.

PMID: 37487022 PMC: 10424294. DOI: 10.1111/jcmm.17875.

A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer.

Ren L, Yang X, Wang W, Lin H, Huang G, Liu Z Front Genet. 2023; 14:1096783.

PMID: 36911392 PMC: 9999016. DOI: 10.3389/fgene.2023.1096783.

Chromobox proteins in cancer: Multifaceted functions and strategies for modulation (Review).

Wang J, Yang B, Zhang X, Liu S, Pan X, Ma C Int J Oncol. 2023; 62(3).

PMID: 36734270 PMC: 9937689. DOI: 10.3892/ijo.2023.5484.

Network analysis of long non-coding RNA expression profiles in common warts.

Tarkhan A, Al-Eitan L, Alkhatib R, Alghamdi M Heliyon. 2022; 8(11):e11790.

PMID: 36458289 PMC: 9706709. DOI: 10.1016/j.heliyon.2022.e11790.

References

Liu S, Meng X . LINC00662 Long Non-Coding RNA Knockdown Attenuates the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Regulating the microRNA-15a-5p/Notch2 Axis. Onco Targets Ther. 2020; 13:7517-7530. PMC: 7429411. DOI: 10.2147/OTT.S256464. View

Wu F, Li J, Du X, Zhang W, Lei P, Zhang Q . Long non‑coding RNA AB019562 promotes cell proliferation and metastasis in human hepatocellular carcinoma. Mol Med Rep. 2017; 16(1):69-74. PMC: 5482116. DOI: 10.3892/mmr.2017.6612. View

Villanueva A . Hepatocellular Carcinoma. N Engl J Med. 2019; 380(15):1450-1462. DOI: 10.1056/NEJMra1713263. View

Zhang W, Xia W, Lv Z, Ni C, Xin Y, Yang L . Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?. Cell Physiol Biochem. 2017; 41(2):755-768. DOI: 10.1159/000458736. View

Zhang E, Li X . LncRNA SOX2-OT regulates proliferation and metastasis of nasopharyngeal carcinoma cells through miR-146b-5p/HNRNPA2B1 pathway. J Cell Biochem. 2019; 120(10):16575-16588. DOI: 10.1002/jcb.28917. View

Dagogo-Jack I, Shaw A . Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2017; 15(2):81-94. DOI: 10.1038/nrclinonc.2017.166. View

Wang F, Xie C, Zhao W, Deng Z, Yang H, Fang Q . Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Clin Exp Med. 2015; 17(1):33-43. DOI: 10.1007/s10238-015-0395-9. View

Ning G, Huang Y, Zhen L, Xu W, Jiao Q, Yang F . Transcriptional expressions of Chromobox 1/2/3/6/8 as independent indicators for survivals in hepatocellular carcinoma patients. Aging (Albany NY). 2018; 10(11):3450-3473. PMC: 6286817. DOI: 10.18632/aging.101658. View

Zhang L, Wang L, Wang Y, Chen T, Liu R, Yang W . LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis. Biomed Pharmacother. 2018; 109:1140-1147. DOI: 10.1016/j.biopha.2018.10.105. View

10.

Li W, Dong X, He C, Tan G, Li Z, Zhai B . LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells. J Exp Clin Cancer Res. 2019; 38(1):183. PMC: 6499991. DOI: 10.1186/s13046-019-1177-0. View

11.

Wheeler L, Watson Z, Qamar L, Yamamoto T, Post M, Berning A . CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer. Oncogenesis. 2018; 7(11):92. PMC: 6255906. DOI: 10.1038/s41389-018-0103-1. View

12.

Wang S, Jiang J, Zhang C, Zhang X, Wang C . Serum lincRNA-p21 expression in primary liver diseases and liver metastatic diseases. Pathol Res Pract. 2019; 215(4):779-783. DOI: 10.1016/j.prp.2019.01.014. View

13.

Lv Y, Shi W, Liu H, Kong X, Dai D . Identification of miR-146b-5p in tissues as a novel biomarker for prognosis of gallbladder carcinoma. Eur Rev Med Pharmacol Sci. 2017; 21(3):518-522. View

14.

Xiao L, Zhou Z, Li W, Peng J, Sun Q, Zhu H . Chromobox homolog 8 (CBX8) Interacts with Y-Box binding protein 1 (YBX1) to promote cellular proliferation in hepatocellular carcinoma cells. Aging (Albany NY). 2019; 11(17):7123-7149. PMC: 6756871. DOI: 10.18632/aging.102241. View

15.

Huang W, Liu J, Yan J, Huang Z, Zhang X, Mao Y . LncRNA LINC00470 promotes proliferation through association with NF45/NF90 complex in hepatocellular carcinoma. Hum Cell. 2019; 33(1):131-139. DOI: 10.1007/s13577-019-00288-8. View

16.

Wang B, Tang J, Liao D, Wang G, Zhang M, Sang Y . Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma. Ann Surg Oncol. 2013; 20 Suppl 3:S684-92. DOI: 10.1245/s10434-013-3171-7. View

17.

Gong Y, Mao J, Wu D, Wang X, Li L, Zhu L . Circ-ZEB1.33 promotes the proliferation of human HCC by sponging miR-200a-3p and upregulating CDK6. Cancer Cell Int. 2018; 18:116. PMC: 6090603. DOI: 10.1186/s12935-018-0602-3. View

18.

Zhang P, Wang F, Wu J, Wu Y, Huang W, Liu D . LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma. J Cell Physiol. 2018; 234(3):2788-2794. DOI: 10.1002/jcp.27095. View

19.

Ding W, Yang H, Gong S, Shi W, Xiao J, Gu J . Candidate miRNAs and pathogenesis investigation for hepatocellular carcinoma based on bioinformatics analysis. Oncol Lett. 2017; 13(5):3409-3414. PMC: 5431310. DOI: 10.3892/ol.2017.5913. View

20.

Fan H, Lv P, Mu T, Zhao X, Liu Y, Feng Y . LncRNA n335586/miR-924/CKMT1A axis contributes to cell migration and invasion in hepatocellular carcinoma cells. Cancer Lett. 2018; 429:89-99. DOI: 10.1016/j.canlet.2018.05.010. View